Candel Therapeutics is a clinical stage biopharmaceutical company that specializes in developing immunotherapies for cancer patients. They have several drugs in various phases of clinical trials to treat cancers such as pancreatic, prostate, lung, and high-grade glioma. Candel Therapeutics was previously known as Advantagene, Inc. and is headquartered in Massachusetts.